Nose surgery blood pressure: how low is too low for the eyes?
NCT ID NCT07832305
First seen Sep 21, 2026 · Last updated Sep 21, 2026
Summary
Researchers compare two blood pressure targets during controlled hypotension for nose surgery to see how each affects blood flow in the eye's optic nerve. Sixty adults having elective rhinoplasty receive anesthesia aimed at either a lower or higher mean arterial pressure. The team measures eye pressure and uses detailed scans before and after surgery to track changes in the tiny blood vessels of the optic nerve and retina.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Two different mean arterial pressure targets during general anesthesia
- What this could lead to
- If one blood pressure target preserves eye blood flow better, it could guide anesthesia practice for nose surgery and other procedures that use controlled hypotension.
- What could go wrong
- This is a small, single-center study in healthy adults, so the results may not apply to older patients or those with eye or heart conditions. The trial measures blood flow changes, not whether patients actually see better or avoid eye damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-50 years * Scheduled for elective rhinoplasty or septorhinoplasty * American Society of Anesthesiologists (ASA) physical status I-II * Willing and able to provide written informed consent Exclusion Criteria: * History of glaucoma, retinal disease, optic neuropathy, or other significant ophthalmologic disease * Previous ocular surgery * High myopia * Uncontrolled hypertension, diabetes mellitus, or other serious systemic disease * ASA physical status III or higher * Development of severe intraoperative hemodynamic instability * Massive intraoperative bleeding * Inadequate OCTA image quality for analysis * Pregnancy * Refusal to participate or withdrawal of consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Controlled hypotension for nasal surgeries are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hitit university
RECRUITINGÇorum, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.